ReviewEuropean journal of pediatrics2013
Educational Paper: Aspects of clinical pharmacology in children--pharmacovigilance and safety.
Review in European journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Physicians' perspectives on adverse drug reactions in pediatric routine care: a survey.World journal of pediatrics : WJP · 2022Article
- Rational Use of Medicines in Neonates: Current Observations, Areas for Research and Perspectives.Healthcare (Basel, Switzerland) · 2018Review
- Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care.European journal of pediatrics · 2016Article
- Adverse drug reactions in neonates and infants: a population-tailored approach is needed.British journal of clinical pharmacology · 2015Article
- Paediatric clinical pharmacology in the UK.Archives of disease in childhood · 2014Review
- Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.European journal of clinical pharmacology · 2014Article
- Pharmacovigilance for children's sake.Drug safety · 2014Article
- Neonatal clinical pharmacology.Paediatric anaesthesia · 2014Review
- Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches.European journal of pediatrics · 2013Article
- Pediatric clinical pharmacology: an introduction to a series of educational papers.European journal of pediatrics · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adverse drug reactions (ADRs) are a significant problem in children, affecting one in ten children in hospital. Within the community, one in 500 children will experience an adverse drug reaction each year. Pharmacovigilance has been useful in detecting suspected ADRs. However, most ADRs are unreported and often not suspected. Education of health professionals in relation to drug toxicity improves the reporting rate of suspected ADRs. Clinical trials are useful to evaluate the efficacy of drugs. They are, however, not the best way of looking at ADRs where surveillance following the widespread use of a drug is more appropriate. Alongside work by the regulatory agencies, independent investigators have helped collate data. This information has been useful in developing guidelines to prevent further cases of drug toxicity. Greater awareness and understanding of drug toxicity in children should result in more rational prescribing.
Indexed as
Identifiers
23111760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.